Aptima® HIV-1 Quant Dx Assay

Dual-claim assay to confirm HIV-1 infection and measure viral load.
 

Description

HIV-1 Detection and Viral Load Monitoring

With performance you can count on, the Aptima HIV-1 Quant Dx assay is a dual-claim assay that can be used to confirm HIV-1 infection and measure viral load for optimal patient management.1 It offers reliable quantitation of HIV-1 RNA across a broad linear range, giving your lab excellent precision and sensitivity for HIV-1 detection and viral load monitoring.

The Aptima HIV-1 Quant Dx Assay intended use is to:

Confirm HIV Infection

Running on the Panther® system, Aptima HIV-1 Quant Dx accurately detects and monitors HIV-1 for reliable, repeatable results.

Monitor Viral Load

Industry-leading precision gives you confidence that any changes in viral load reflect clinical changes in the patient—not variations in the assay.

Features

Curabitur accumsan auctor ipsum, eget aliquam tellus dignissim id. Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas. Sed vehicula scelerisque lacus id ultrices. Nullam vestibulum pharetra orci vel venenatis. Proin in pulvinar lorem, sed tempor felis. Cras tincidunt non felis imperdiet lobortis. Nulla nec nisl tempor, tincidunt lectus quis, tincidunt leo. Quisque laoreet ac velit fringilla tempor. Nullam a sollicitudin tellus. Curabitur et nulla quis diam porttitor tempor sed eu magna. Sed magna magna, fringilla vel luctus at, eleifend vitae risus. Fusce maximus pellentesque risus at ornare. Ut fermentum semper elit.

More Products

Panther Fusion® Open Access™

Laboratory Developed Tests (LDTs) are an essential part of diagnostics. Patients with certain medical conditions depend on these in-house developed tests when other options are not available. Save time and increase efficiency by consolidating your LDTs and IVD assays on the fully automated, sample-to-result, Panther Fusion system using the Open Access™ functionality.

Aptima® Vaginal Health

The Aptima vaginitis panel from Hologic consists of molecular nucleic acid amplification tests (NAAT) to aid in the detection of vaginosis and vaginitis. Our assays detect the three most common causes of infectious vaginitis: bacterial vaginosis, candida vaginitis and trichomoniasis.

Aptima® HIV-1 Quant Dx Assay

Dual-claim assay to confirm HIV-1 infection and measure viral load.
 

Aptima® Herpes Simplex 1 & 2 assay

Globally, over 4.1 billion people are infected with HSV-1 and HSV-2 and the signs and symptoms can overlap.1 It is only through laboratory tests that these subtypes can be differentiated, which is important for managing herpes infections and identifying the risk of transmission to neonates and among sex partners.2,3